University

Jay Harris Levy, M.D. Has Been Reviewed and Approved By FL Top Docs

Retrieved on: 
Monday, May 16, 2022 - 8:00am
Diplomate of National Board, American Academy, American College, Association for Research in Vision and Ophthalmology, Research, American Academy of Ophthalmology, Retina, Surgeon, Environment, Health, Association, University, Johns Hopkins, Society, American College of Surgeons, Adventist Health, Jackson Memorial Hospital, National Board of Medical Examiners, American Board of Commissioners for Foreign Missions, Johns Hopkins Hospital, American Board of Ophthalmology, Travel, Sinai Hospital, Board of High School and Intermediate Education Uttar Pradesh, Health insurance, Medicine, Ophthalmology

SCOTCH PLAINS, N.J., May 16, 2022 /PRNewswire-PRWeb/ -- Dr. Jay Harris Levy is one of the most widely known and respected retina surgeons and vitreous specialists in South Florida. A native of Miami, Dr. Levy received his medical degree from the University of Miami and completed his internship at Jackson Memorial Hospital. He served as Chief Resident during his Ophthalmology Residency at Sinai Hospital of Baltimore, in association with the Johns Hopkins Hospital. As a Fellow in Vitreoretinal Disease and Surgery, Dr. Levy received additional subspecialty training at White Memorial Medical Center in Los Angeles.

Key Points: 
  • Dr. Jay Harris Levy of the Retina Macular Specialists of Miami has been reviewed and approved by FL Top Docs for 2022.
  • SCOTCH PLAINS, N.J., May 16, 2022 /PRNewswire-PRWeb/ -- Dr. Jay Harris Levy is one of the most widely known and respected retina surgeons and vitreous specialists in South Florida.
  • A native of Miami, Dr. Levy received his medical degree from the University of Miami and completed his internship at Jackson Memorial Hospital.
  • He served as Chief Resident during his Ophthalmology Residency at Sinai Hospital of Baltimore, in association with the Johns Hopkins Hospital.

SIFI RECEIVES FAVORABLE FEEDBACK FROM THE US FDA ON AKANTIOR® FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS

Retrieved on: 
Monday, May 16, 2022 - 8:00am
Company, Disease, Polyhexanide, Acanthamoeba keratitis, Eye, Incidence, NCE, Cyst, Patient, Quality of life, Severe cognitive impairment, SIFI, Research, Patent, FDA, Trophozoite, Massachusetts Eye and Ear, Transplant, University, Orphan, NDA, American Journal, Illinois Eye and Ear Infirmary, AK, The Company, Ophthalmology, MD, Fungal keratitis, CEO, Pharmaceutical industry, Acanthamoeba, New chemical entity

ABOUT AKANTIOR: AKANTIOR (polihexanide) stands to become the first approved drug for the treatment of acanthamoeba keratitis in the world.

Key Points: 
  • ABOUT AKANTIOR: AKANTIOR (polihexanide) stands to become the first approved drug for the treatment of acanthamoeba keratitis in the world.
  • Polihexanide is also being developed by SIFI for the treatment of fungal keratitis for which indication it also has FDA Orphan Drug Designation.
  • ABOUT Acanthamoeba Keratitis (AK): AK is a rare, acute, severe parasitic corneal infection caused by Acanthamoeba, a free-living amoeba.
  • ABOUT SIFI: SIFI is a leading international ophthalmic company, headquartered in Italy, focusing on eye care since 1935.

The Linux Foundation Initiates "World of Open Source" Research Series

Retrieved on: 
Monday, May 16, 2022 - 8:00am
Scott Logic, Linux, Linux Foundation, VP, Research, University of Erlangen–Nuremberg, EUR, Certification, Public sector, University, Government, Motivation, Bird, Node.js, Executive, CTO, LF, University Library of the TU Berlin and UdK, Collaboration, Ecosystem, Public health, Organization, Adoption, SME, Growth, CEO, Renewable energy, Creative industries, EU, OpenForum Europe

VALENCIA, Spain, May 16, 2022 /PRNewswire/ -- The Linux Foundation, a global nonprofit organization enabling mass innovation through open source, today launches the World of Open Source research series with its initial focus on the European community. The initiative will be championed by LF Research in collaboration with several European distribution and research partners. Furthermore, key executives of the Linux Foundation and partners will be speaking at KubeCon in Valencia, Spain this week as they kickstart the research series and meet with the extended open source and cloud native communities.

Key Points: 
  • VALENCIA, Spain, May 16, 2022 /PRNewswire/ -- The Linux Foundation, a global nonprofit organization enabling mass innovation through open source, today launches the World of Open Source research series with its initial focus on the European community.
  • Furthermore, key executives of the Linux Foundation and partners will be speaking at KubeCon in Valencia, Spain this week as they kickstart the research series and meet with the extended open source and cloud native communities.
  • "OpenForum Europe is pleased to partner with the Linux Foundation to promote this timely research series and upcoming survey on the state of open source in Europe.
  • The Linux Foundation is the world's leading home for collaboration on open source software, open standards, open data, and open hardware.

SIFI RECEIVES FAVORABLE FEEDBACK FROM THE US FDA ON AKANTIOR® FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS

Retrieved on: 
Monday, May 16, 2022 - 8:00am
Company, Disease, Polyhexanide, Acanthamoeba keratitis, Eye, Incidence, NCE, Cyst, Patient, Quality of life, Severe cognitive impairment, SIFI, Research, Patent, FDA, Trophozoite, Massachusetts Eye and Ear, Transplant, University, Orphan, NDA, American Journal, Illinois Eye and Ear Infirmary, AK, The Company, Ophthalmology, MD, Fungal keratitis, CEO, Pharmaceutical industry, Acanthamoeba, New chemical entity

ABOUT AKANTIOR: AKANTIOR (polihexanide) stands to become the first approved drug for the treatment of acanthamoeba keratitis in the world.

Key Points: 
  • ABOUT AKANTIOR: AKANTIOR (polihexanide) stands to become the first approved drug for the treatment of acanthamoeba keratitis in the world.
  • Polihexanide is also being developed by SIFI for the treatment of fungal keratitis for which indication it also has FDA Orphan Drug Designation.
  • ABOUT Acanthamoeba Keratitis (AK): AK is a rare, acute, severe parasitic corneal infection caused by Acanthamoeba, a free-living amoeba.
  • ABOUT SIFI: SIFI is a leading international ophthalmic company, headquartered in Italy, focusing on eye care since 1935.

Nicox Announces a New Governance Structure

Retrieved on: 
Monday, May 16, 2022 - 6:30am
Kepler, Sanofi, University, Board of directors, D-Company, Duane syndrome, Euronext Paris, European Ophthalmic Pathology Society, HEC, LLC, University Hall (Uppsala University), Master of Science, Andreas, Investment, Allergic conjunctivitis, Therapy, Audit committee, NCX, Organic chemistry, Latanoprost, Board, Ocular hypertension, Founder, Business, Royal institute, Company, Director, COX, Pharmacia, Johannes Kepler, Pharma, HMR, KTH Royal Institute of Technology, MBA, R, Bausch & Lomb, Leadership, Patient, Compartment, Intraocular pressure, Institute of International Finance, Roussel Uclaf, Marketing, Fluticasone, Pharmacia & Upjohn, Glaucoma, Management, Pharmaceutical industry, Fine chemical, Ophthalmology, NicOx

Michele Garufi will remain as Board member of Nicox SA.

Key Points: 
  • Michele Garufi will remain as Board member of Nicox SA.
  • Jean-Franois Labb has served as a member of Nicox Board of Directors since 2010 and has been the Chairman of the Audit Committee of Nicox since 2013.
  • Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health.
  • Nicox disavows any obligation to correct or to update the information contained in analyst reports.

SOM Biotech signs licensing agreement with the University of Minnesota

Retrieved on: 
Monday, May 16, 2022 - 7:00am
Disease, Patient, SRA, Becker muscular dystrophy, SOM Biotech, Duchenne, Research, Time, Invention, Toxicity, University, Data mining, Drug discovery, SOM, Pharmaceutical industry

SOM Biotech (SOM or the Company), a clinical-stage biopharmaceutical company with a proprietary AI-based drug discovery technology and a focus on neurological orphan diseases, today announces that it has signed a licensing agreement with the University of Minnesota.

Key Points: 
  • SOM Biotech (SOM or the Company), a clinical-stage biopharmaceutical company with a proprietary AI-based drug discovery technology and a focus on neurological orphan diseases, today announces that it has signed a licensing agreement with the University of Minnesota.
  • The work under the SRA resulted in inventions covering nine potential product candidates, which SOM chose to license exclusively from the University of Minnesota.
  • SOM is currently conducting additional preclinical studies at the University of Minnesota to select the best potential candidates to take forward into development for Duchenne and Becker muscular dystrophy.
  • Ral Insa, Chief Executive Officer of SOM Biotech, said: This agreement with the University of Minnesota, a leading global research university, shows the exceptional value provided by our SOMAIPRO platform and its unique approach to AI-based drug discovery.

Otis College of Art and Design Announces Donation from the Spiegel Family Fund to Repay Student Loans for the Class of 2022

Retrieved on: 
Sunday, May 15, 2022 - 11:14pm
Education, Other Education, University, Urban Outfitters, Employment, Education, Art, Stanford University, Fine art, Housing, Otis College of Art and Design, Pixar, Dream, KORA Organics, Spiegel, Fulbright Program, Creative economy (economic system), Color, Otis, Nike, Snap Inc., Guggenheim, Communication, DreamWorks, Netflix, Time, Digital media, Student, Creative industries, College, John White (art historian), Faculty, Fashion design, Environmental design, Fund, Apple, Communication Arts (magazine), Letter, Product design, MacArthur, Management, Tutoring, Medicine, Design, Mattel

The donation will allow for the repayment of the outstanding student debt of students in the graduating Class of 2022.

Key Points: 
  • The donation will allow for the repayment of the outstanding student debt of students in the graduating Class of 2022.
  • This is the largest single gift in the history of Otis College and will reduce student debt for emerging artists and designers and their families.
  • Otis College is incredibly grateful for this historic gift from Miranda Kerr and Evan Spiegel, which will be life-changing for the Class of 2022 and their families, said Charles Hirschhorn, President of Otis College of Art and Design.
  • Otis College of Art and Design is an extraordinary institution that encourages young creatives to find their artistic voices and thrive in a variety of industries and careers, said Spiegel and Kerr, founders of The Spiegel Family Fund.

Athena Global Education and Carolina University announce transnational partnership to serve the global student community

Retrieved on: 
Sunday, May 15, 2022 - 8:00am
MBA, University, International, Public health, Data science, Doctorate, Gulf Coast of the United States, Carolina University, Partnership, Student, Program, Technology, CEO, Management

OXFORD, England, May 15, 2022 /PRNewswire/ -- Athena Global Education (UniAthena) and Carolina University (CU) are pleased to announce a partnership to offer MBA programs globally.

Key Points: 
  • OXFORD, England, May 15, 2022 /PRNewswire/ -- Athena Global Education (UniAthena) and Carolina University (CU) are pleased to announce a partnership to offer MBA programs globally.
  • This is a significant transnational provisioning agreement which will offer the UniAthena/CU completion programs throughout the 113 countries currently served by UniAthena.
  • The programs will be delivered online, however students have provision to complete the program at university premises also.
  • Carolina University is proud to partner with UniAthena to continue its mission in offering quality educational opportunities for a growing global market.

Athena Global Education and Carolina University announce transnational partnership to serve the global student community

Retrieved on: 
Sunday, May 15, 2022 - 8:00am
MBA, University, International, Public health, Data science, Doctorate, Gulf Coast of the United States, Carolina University, Partnership, Student, Program, Technology, CEO, Management

OXFORD, England, May 15, 2022 /PRNewswire/ -- Athena Global Education (UniAthena) and Carolina University (CU) are pleased to announce a partnership to offer MBA programs globally.

Key Points: 
  • OXFORD, England, May 15, 2022 /PRNewswire/ -- Athena Global Education (UniAthena) and Carolina University (CU) are pleased to announce a partnership to offer MBA programs globally.
  • This is a significant transnational provisioning agreement which will offer the UniAthena/CU completion programs throughout the 113 countries currently served by UniAthena.
  • The programs will be delivered online, however students have provision to complete the program at university premises also.
  • Carolina University is proud to partner with UniAthena to continue its mission in offering quality educational opportunities for a growing global market.

APPLE CEO TIM COOK CHALLENGES GALLAUDET UNIVERSITY GRADUATES: "WHATEVER YOU DO, LEAD WITH YOUR VALUES"

Retrieved on: 
Saturday, May 14, 2022 - 5:30pm
Universe, Assistant, Caselli, Education, Lauren Ridloff, Jean St. Clair (deaf actress), Houston Field House, Carl Croneberg, AI, Psychology, Steinhardt School of Culture, Education, and Human Development, Environment, Multimedia, Language, Walking Dead, American Sign Language, Hearing, Child, Field house, Deafblindness, ASL, Learning, Boston University, CODA, Community, Linguistics, Undergraduate education, Research, Mentorship, Culture, Humanity (virtue), Sign language, Awareness, List of common film awards categories, Life, Time, Empathy, Student, Marvel Cinematic Universe, Commitment, University, Communication, Technology, Apple TV, Cordano, Face, Acquisition, Apple, Commencement, Eternal, Civil engineering, Medicine, Public relations, Management, Toy, Color, Gallaudet University, Academy Awards

WASHINGTON, May 14, 2022 /PRNewswire/ -- Gallaudet University celebrated the achievements of over 400 undergraduate and graduate students as they received their degrees during the University's 152nd Commencement ceremony in the Field House on the school's Washington, D.C. campus. Gallaudet is the only university in the world where deaf, deafblind and hard of hearing students live and learn bilingually in American Sign Language and English. To view both ceremonies please visit: Graduate Commencement Ceremony and Undergraduate Commencement Ceremony. 

Key Points: 
  • Gallaudet is the only university in the world where deaf, deafblind and hard of hearing students live and learn bilingually in American Sign Language and English.
  • Apple CEO Tim Cook, the leader of one of the world's most innovative companies, delivered the keynote address .
  • "Gallaudet has prepared you for a lifetime of discovery," said Cook.
  • The university enrolls over 1,600 students in more than 40 undergraduate majors and many master's and doctoral programs.